Disclosed is a compound of formula (I), wherein R represents hydrogen or alkyl and the remaining substituents are as defined in the specification. The compounds are monoamine neurotransmitter reuptake inhibitors useful in the treatment of central nervous system disorders.
Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors